Familial Cancer

Papers
(The TQCC of Familial Cancer is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Ninth International Symposium on Hereditary Breast and Ovarian Cancer37
Screening for pancreatic cancer in high-risk individuals using MRI: optimization of scan techniques to detect small lesions32
Mainstreamed genetic testing of breast cancer patients: experience from a single surgeon’s practice in a large US Academic Center26
In memoriam Professor Thierry Frébourg21
2022 CGA-IGC Annual Meeting: The collaborative group of the Americas on Inherited Gastrointestinal Cancer November 11–13, 202220
Balancing the burden and benefits of colonoscopy in Lynch Syndrome14
Endoscopic screening for identification of signet ring cell gastric cancer foci in carriers of germline pathogenic variants in CDH114
Identification of a germline deep intronic PTEN-deletion leading to exonization through whole genome and targeted RNA sequencing13
Identifying the BRCA1 c.-107A > T variant in Dutch patients with a tumor BRCA1 promoter hypermethylation13
The best linear unbiased prediction (BLUP) method as a tool to estimate the lifetime risk of pancreatic ductal adenocarcinoma in high-risk individuals with no known pathogenic germline variants12
The Italian registry of families at risk for pancreatic cancer (IRFARPC): implementation and evolution of a national program for pancreatic cancer surveillance in high-risk individuals12
Recurring pathogenic variants in the BRCA2 gene in the Ethiopian Jewish population. Founder mutations?12
Re-evaluating cancer risks associated with the CHEK2 p.Ser428Phe Ashkenazi Jewish founder pathogenic variant11
In deep bioinformatic characterization of a novel fumarate hydratase variant FH c.199T > G; (p.Tyr67Asp) in hereditary leiomyomatosis and renal cell carcinoma11
Germline p.R181H variant in TP53 in a family exemplifying the genotype-phenotype correlations in Li-Fraumeni syndrome11
A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and/or ovarian cancer in three tertiary Cancer Centres in Ireland11
Endoscopic indicators in patients with familial adenomatous polyposis undergoing duodenal resections – a nationwide Danish cohort study with long-term follow-up10
Inherited BRCA1 and RNF43 pathogenic variants in a familial colorectal cancer type X family10
PTCH2 is not a strong candidate gene for gorlin syndrome predisposition8
A patient with very early onset FH-deficient renal cell carcinoma diagnosed at age seven8
Physicians’ experience, practice and education, on genetic testing and genetic counseling: a nationwide survey study in Greece7
Correction to: Letter to the Editor—Recent advances in Lynch syndrome7
Correction: Clinician perspectives on policy approaches to genetic risk disclosure in families6
Barriers to completion of cascade genetic testing: how can we improve the uptake of testing for hereditary breast and ovarian cancer syndrome?6
Outcomes of retesting in patients with previously uninformative cancer genetics evaluations6
Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer6
Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake6
Thirty-year compliance with a surveillance program for patients with familial adenomatous polyposis6
Truncating TINF2 p.Tyr312Ter variant and inherited breast cancer susceptibility5
The paradigm of hematological malignant versus non-malignant manifestations, driven by primary immunodeficiencies: a complex interplay5
Cascade genetic testing: an underutilized pathway to equitable cancer care?5
In memoriam: Gloria Petersen, PhD (1950-2023)5
Li Fraumeni Syndrome predisposes to gastro-esophageal junction tumours5
Laboratory variation in the grading of dysplasia of duodenal adenomas in familial adenomatous polyposis patients5
CGA-IGC 2023 Abstracts5
Strategies for diagnosis and management of CMMRD in low-resource countries: report of a Tunisian family5
The response of pancreatic acinar cell carcinoma to platinum and olaparib therapy in a germline BRCA2 variant carrier: case report and literature review5
Men with metastatic prostate cancer carrying a pathogenic germline variant in breast cancer genes: disclosure of genetic test results to relatives5
Utility of interim blood tests for cancer screening in Li-Fraumeni syndrome5
Prevalence of cardiometabolic outcomes in women who underwent salpingo-oophorectomy to prevent hereditary breast and ovarian cancer: a meta-analysis5
A comprehensive characterization of the spectrum of MUTYH germline pathogenic variants in Latin America5
Von Hippel-Lindau disease and rapidly progressing pheochromocytomas in siblings5
Willingness of individuals with Li-Fraumeni syndrome to participate in a cancer prevention trial: a survey study5
A family-based approach to cascade genetic testing in a pediatric cancer genetics clinic4
Healthcare professionals’ perspectives on implementation of universal tumor DNA testing in ovarian cancer patients: multidisciplinary focus groups4
Detecting inversions in routine molecular diagnosis in MMR genes4
Challenges and opportunities for Lynch syndrome cascade testing in the United States3
A case of Rothmund-Thomson syndrome originally thought to be a case of Bloom syndrome3
A de novo pathogenic variant in the MSH6 gene in a 52 years-old woman3
Expanding access to genetic testing for pancreatic cancer3
Case review of perivascular epithelioid cell tumor occurring in patients with Li-Fraumeni syndrome3
Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variants3
The psychological impact and experience of breast cancer screening in young women with an increased risk of breast cancer due to neurofibromatosis type 13
Fibroadenoma in vulval ectopic breast tissue in a patient with PTEN Hamartoma Tumour Syndrome3
Review of the cost-effectiveness of surveillance for hereditary pancreatic cancer3
Correction: Outcomes of retesting in patients with previously uninformative cancer genetics evaluations3
Colonoscopy surveillance in Lynch syndrome is burdensome and frequently delayed3
Preimplantation genetic testing in patients with genetic susceptibility to cancer3
Constitutional 2p16.3 deletion including MSH6 and FBXO11 in a boy with developmental delay and diffuse large B-cell lymphoma3
Clinical and imaging modality factors impacting radiological interpretation of breast screening in young women with neurofibromatosis type 13
Sarcomas arising in MEN1 patients: demonstrating LOH of the MEN1 locus and loss of menin expression3
Myelodysplastic syndrome with dual germline RUNX1 and DDX41 variants: a rare genetic predisposition case3
0.044605016708374